Authors:
Csepregi, A
Nemesanszky, E
Luettig, B
Obermayer-Straub, P
Manns, MP
Citation: A. Csepregi et al., LKM3 autoantibodies in hepatitis C cirrhosis: A further phenomenon of the HCV-induced autoimmunity, AM J GASTRO, 96(3), 2001, pp. 910-911
Citation: Aa. Csepregi et E. Nemesanszky, Mitochondrial autoantibodies to the components of 2-oxoacid dehydrogenase complex are early markers of primary biliary cirrhosis, JCR-J CLIN, 6(2), 2000, pp. 109-109
Citation: A. Csepregi et E. Nemesanszky, Acute cholestatic liver injury caused by azathioprine in early rheumatoid arthritis, JCR-J CLIN, 6(2), 2000, pp. 112-113
Authors:
Biro, L
Varga, L
Par, A
Nemesanszky, E
Csepregi, A
Telegdy, L
Ibranyi, E
David, K
Horvath, G
Szentgyorgyi, L
Nagy, I
Dalmi, L
Abonyi, M
Fust, G
Horanyi, M
Citation: L. Biro et al., Changes in the acute phase complement component and IL-6 levels in patients with chronic hepatitis C receiving interferon alpha-2b, IMMUNOL LET, 72(2), 2000, pp. 69-74
Authors:
Halmos, B
Szalay, F
Cserniczky, T
Nemesanszky, E
Lakatos, P
Barlage, S
Schmitz, G
Romics, L
Csaszar, A
Citation: B. Halmos et al., Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population, DIG DIS SCI, 45(6), 2000, pp. 1091-1095
Authors:
Biro, L
Varga, L
Par, A
Nemesanszky, E
Telegdy, L
Ibranyi, E
David, K
Horvath, G
Szentgyorgyi, L
Nagy, I
Dalmi, L
Abonyi, M
Fust, G
Horanyi, M
Csepregi, A
Citation: L. Biro et al., C5b-9 and interleukin-6 in chronic hepatitis C - Surrogate markers predicting short-term response to interferon alpha-2b, SC J GASTR, 35(10), 2000, pp. 1092-1096
Authors:
Csepregi, A
Rojkovich, B
Nemesanszky, E
Poor, G
Hejjas, M
Horanyi, M
Citation: A. Csepregi et al., Chronic seropositive polyarthritis associated with hepatitis B virus-induced chronic liver disease: a sequel of virus persistence, ARTH RHEUM, 43(1), 2000, pp. 232-233